Page 132 | Certara

Press Release

Certara Announces Pricing of its Upsized Initial Public Offering

PRINCETON, NJ.— December 10, 2020 – Certara, Inc. (“Certara”), a global leader in biosimulation, today…

CertaraDecember 10, 2020

Press Coverage

Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China

The Pharmacy department of the Shanghai Chest Hospital is dedicated to developing and applying model-informed…

CertaraDecember 3, 2020

On-Demand Webinar

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango

More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…

CertaraDecember 2, 2020

Brochure

BaseCase Market Access

CertaraNovember 30, 2020

Press Coverage

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

CertaraNovember 20, 2020

Publication

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

CertaraNovember 13, 2020

Blog

Formatting Annotated Case Report Forms (aCRFs): Not Submitted Annotations and SDRG

Simplify aCRFs with insights on “Not Submitted” annotations, reviewer’s guide tips, and define origin column…

CertaraNovember 13, 2020

Press Coverage

How PBPK Modeling Can Replace Drug-Drug Interaction Studies

Patients often take more than one drug at a time, especially elderly patients and those…

CertaraNovember 12, 2020

Case Study

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

CertaraNovember 9, 2020

Press Release

Certara Opens New China Office in Shanghai

Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …

CertaraNovember 9, 2020

Certara Announces Pricing of its Upsized Initial Public Offering

Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango

BaseCase Market Access

Getting Real with RWE

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Formatting Annotated Case Report Forms (aCRFs): Not Submitted Annotations and SDRG

How PBPK Modeling Can Replace Drug-Drug Interaction Studies

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

Certara Opens New China Office in Shanghai

Newsletter sign up

Quick links

Solutions

Contact